Efficacy and safety of AP26113 in ALK+ non-small cell lung cancer (NSCLC), including patients with brain metastases

The requested reference [8675e119d7484c10cbca0cfa53c11368b44efb4b] no longer exists in our database. It has been replaced by the current reference: [4d5bdd0d4ab686086a0c2e042a2955d8ad746186]

Authors
Category Primary study
JournalLung Cancer
Year 2015
This article has no abstract
Epistemonikos ID: 92bbcab87dca85cf16cd42e71ab89e1cf22384c9
First added on: Feb 06, 2025